2023 6-month group forecast
Nov 6 (Reuters) -
Towa Pharmaceutical Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
6 Months to 6 Months to
Sep 30, 2023 Sep 30, 2023
LATEST PREVIOUS
FORECAST FORECAST
Sales 107.30 104.60
Operating 7.00 5.80
Recurring 10.20 5.60
Net 6.90 3.40
EPS 140.18 yen 69.08 yen
NOTE - Towa Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T
Recent news on TOWA PHARMACEUTICAL
See all newsTable: Towa Pharmaceutical -Q1 group results
Notice Of Acquisition Of Shares Of Tanabe Pharma Factory And Transfer Of Manufacturing And Marketing Approvals
Brief: Breckenridge Launches Tofacitinib Tablets, Generic Equivalent Of Xeljanz By Pfizer
Table: Towa Pharmaceutical -2025/26 parent results
Table: Towa Pharmaceutical -2025/26 group results